Related Experiment Video
Updated: May 15, 2026

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma
Published on: August 31, 2022
Hepatoblastoma evaluated by 18F-fluoromethyl choline PET/CT
Matthanja Bieze1, Thomas M van Gulik, Roelof J Bennink
1Department of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. M.Bieze@amc.uva.nl
Abstract:
Hepatoblastoma is a rare carcinoma mostly seen in children. Neoadjuvant chemotherapy followed by resection and adjuvant chemotherapy is the optimal treatment. We present the case of an 18-year-old woman who presented with abdominal pain, nausea, bloating, and fatigue. MRI showed 3 hepatic lesions with high signal intensity on arterial phase T1-weighted images and slight washout on the late phase, suggestive for hepatocellular carcinoma. Laboratory examinations revealed plasma α-feto-protein of 114,245 μg/L. Subsequent baseline and posttreatment F-fluoromethyl choline PET/CT were performed to possibly evaluate extent of the disease and assess disease response after neoadjuvant chemotherapy.

